Trial intelligence / Profile preview

Brand-Name vs Generic Tacrolimus in Transplant Recipients

NCT02014103Phase 4Completed

Sponsor
University of Cincinnati
Start
Mar 2015
Primary completion
Aug 2015
Modality
RNA-Targeting Small Molecules
Countries
1
01

Overview

A Phase 4 trial of tacrolimus in transplant complication, sponsored by University of Cincinnati. Started Mar 2015; status: completed.

02

Drugs

tacrolimus
03

Conditions

transplant complication

Beyond the preview

Go deeper on NCT02014103.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT02014103.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call